来自胃肠道癌的腹转移的新兴治疗方法
Aleksandra Sikora1, Kevin M Sullivan2, Sean Dineen3
1Department of Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland.
Molecular therapy. Oncology
|April 10, 2024
概括
本综述探讨了胃肠道癌症产生的腹转移的当前和新兴治疗方法. 新型疗法,如型病毒和纳米技术,显示出改善患者治疗结果的前景.
科学领域:
- 胃肠道瘤学 胃肠道瘤学
- 手术瘤学手术瘤学
- 实验性治疗学实验性治疗学
背景情况:
- 来自胃肠道癌的腹转移带来了重大治疗挑战.
- 目前的治疗依赖于全身化疗或大手术,通常是高热性腹腔内化疗.
- 对于新且有效的治疗策略有着至关重要的需求.
研究的目的:
- 审查胃肠道恶性瘤中腹转移的现有和新兴疗法.
- 专注于从2015年起出版的最新文学作品.
- 提供对有前途的新型治疗方式的概述.
主要方法:
- 从2015年到现在的研究综合文献综述.
- 分析系统疗法和用腹腔内化疗进行细胞减小手术的数据.
- 评估关于新疗法的临床前和早期研究.
主要成果:
- 已建立的治疗方法包括全身疗法和细胞减小,使用高热性腹腔内化学疗法 (HIPEC) 或加压腹腔内喷雾剂化学疗法 (PIPAC).
- 目前正在研究的新兴疗法包括型病毒疗法,采用细胞疗法,生物疗法,细菌疗法和纳米技术.
- 这些新的方法,虽然在很大程度上是临床前的,但显示出治疗腹转移的潜力.
结论:
- 针对腹转移,正在研究各种新策略.
- 这些不断发展的治疗方法为改善患者的结果和生活质量提供了希望.
- 进一步的研究和数据共享对于推动药物发现和优化治疗至关重要.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


